Bridgeway Capital Management, LLC Abiomed Inc Transaction History

Bridgeway Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$130.51 - $196.01 $913,569 - $1.37 Million	-7,000 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$250.96 - $284.94 $803,072 - $911,808	-3,200 Reduced 31.37%	7,000 $1.82 Million
Q1 2019 May 15, 2019	SELL	$276.39 - $362.25 $856,809 - $1.12 Million	-3,100 Reduced 23.31%	10,200 $2.91 Million
Q4 2018 Feb 14, 2019	SELL	$281.08 - $444.25 $5.37 Million - $8.49 Million	-19,100 Reduced 58.95%	13,300 $4.32 Million
Q2 2018 Aug 14, 2018	SELL	$278.07 - $446.21 $4.17 Million - $6.7 Million	-15,010 Reduced 31.66%	32,400 $13.3 Million
Q1 2018 May 15, 2018	BUY	$192.49 - $295.85 $2.89 Million - $4.44 Million	15,010 Added 46.33%	47,410 $13.8 Million
Q4 2017 Feb 14, 2018	BUY	$168.78 - $199.74 $5.47 Million - $6.47 Million	32,400	32,400 $6.07 Million

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.